Found 22 matching trials
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NAThe clinical trial was designed as a single-arm, open-label clinical study,...
Location
The Second Affiliated Hospital of Soochow University
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
PHASE1This is a single-arm, single-center, interventional, dose-escalation clinic...
Location
Anhui Provincial Hospital
On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma
PHASE1The main research objective is to evaluate the safety, tolerability, and ph...
Location
PersonGen.Anke Cellular Therapeutice Co., Ltd.
Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL
PHASE1CD19-CAR-γδT cell therapy is a cellular immunotherapy targeting CD19 to per...
Location
Biotherapeutic Department of Chinsese PLA Gereral Hospital
Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
EARLY_PHASE1This clinical trial aims to investigate the safety, optimal dosage, and eff...
Location
The First Affiliated Hospital of Soochow University
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
PHASE1This study is an open-label, single-arm clinical trial designed to evaluate...
Location
The first affiliated hospital of fujian medical university
Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation
NAThis is an open single-arm clinical study aimed at evaluating the efficacy ...
Location
Hebei yanda Ludaopei Hospital
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection
PHASE1B7-H3 is expressed at low levels in normal tissues but overexpressed in var...
Location
Dushu Lake Hospital Affiliated to Soochow University
Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors
NAThis is an open, single-arm, single-center, interventional clinical study. ...
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
PHASE1The third generation of GPC3/mesothelin targeted CAR-γδT cells have been co...
Location
The Second Affiliated Hospital of Guangzhou Medical University